You have no items in your shopping cart.
Description
Research Area
Images & Validation
−| Tested Applications | ELISA |
|---|---|
| Application Notes |
Key Properties
−| Reactivity | Mouse |
|---|---|
| Sample Types | serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
| Assay Type | Sandwich |
| Assay Time | 3.5h |
| Range | 0.63-40 ng/mL |
| Sensitivity | 0.242 ng/mL |
| Concentration | 40 ng/mL |
Procedure & Performance
−| Assay Principle | |
|---|---|
| Kit Components | |
| Reagent Preparation | |
| Assay Procedure | |
| Materials Required | |
| Precision | |
| Calculation of Results | |
| Curve Fitting Softwares |
Storage & Handling
−| Storage | Refer to the Storage Guidelines in the Manual |
|---|---|
| Expiration Date | Please enquire. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Mouse Soluble Cluster of Differentiation 146 (sCD146) ELISA Kit [orb1947050]
Mouse
0.32-20ng/mL
0.19 ng/mL
48 T, 96 TMF-Mouse sCD146(Soluble Cluster of Differentiation 146) ELISA Kit [orb3203134]
Mouse
0.31-20ng/mL
0.16ng/mL
48 T, 96 TFS-Mouse sCD146(Soluble Cluster of Differentiation 146) ELISA Kit [orb3196803]
Mouse
0.31-20ng/mL
0.12ng/mL
48 T, 96 T

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
UniProt Details
−Filter by Applications
Filter by Species
Ahmad Joshkon 1, Wael Traboulsi 2, Magali Terme 3, Richard Bachelier 4, Hussein Fayyad-Kazan 5, Françoise Dignat-George 6, Alexandrine Foucault-Bertaud 7, Aurelie S Leroyer 6, Nathalie Bardin 8, Marcel Blot-Chabaud 7 Soluble CD146 cooperates with VEGF-A to generate an immunosuppressive microenvironment in CD146-positive tumors: interest of a combined antibody-based therapy Mol Cancer Ther, (2024)
Applications
Reactivity




